搜索结果: 1-13 共查到“临床医学 Stem cell”相关记录13条 . 查询时间(0.102 秒)
印第安纳大学医学院的研究人员成功地将中枢神经系统中的一种胶质细胞重新编程为新的神经元，以促进脊髓损伤后的恢复——揭示了利用这种细胞进行再生医学的尚未开发的潜力。
研究小组于 3 月 5 日在《Cell Stem Cell》杂志上发表了他们的研究结果。这是科学家首次报道在脊髓损伤后将 NG2 胶质细胞（中枢神经系统中的一种支持细胞）改造成功能性神经元。
Rac and Cdc42 GTPases control hematopoietic stem cell shape, adhesion, migration, and mobilization
Rac Cdc42
2014/12/12
Critical to homeostasis of blood cell production by hematopoietic stem/progenitor (HSC/P) cells is the regulation of HSC/P retention within the bone marrow microenvironment and migration between the b...
西安交通大学医学院血液系统疾病课件 Hematopoietic stem cell transplantation (HSCT)
西安交通大学医学院 血液系统疾病 课件 Hematopoietic stem cell transplantation (HSCT)
2014/8/4
西安交通大学医学院血液系统疾病课件 Hematopoietic stem cell transplantation (HSCT)。
Twenty Years of Experience on Stem Cell Transplantation in Iran
Hematopoietic Stem Cell Transplantation Leukemia Beta-Thalassemia
2015/9/29
Background: Hematopoietic stem cell transplantation (HSCT) is a new window to therapy of many diseases. From March 1991 through April 2011, a total of 3237 HSCT were performed in the Hematology-Oncolo...
中国医学科学院实验血液学国家重点实验室程涛教授等应邀在“细胞”子刊Cell Stem Cell论坛栏发表文章介绍中国干细胞研究现状
程涛教授 细胞 Cell Stem Cell论坛栏 中国干细胞 研究现状
2012/2/23
近些年来中国在干细胞研究领域的投入飞速增长，巨大的资金投入、基础研究设施的建设和一流人才的回归使这一领域的研究获得了丰厚的成果。但是飞速发展也给我国带来了在政策，管理和临床预期方面的严峻挑战。
Visionary stem cell technique offers new potential to treat blindness
Visionary stem cell technique new potential blindness
2010/10/25
Scientists funded by the Medical Research Council (MRC) are pioneering a stem cell treatment to replace diseased parts of the retina, which could lead to a future treatment for retinal diseases that a...
Background: Human embryonic stem (hES) cells have the unrivaled ability to differentiate into any specialized cell type. Significant attention is currently directed to the biological and therapeutic c...
Hematopoietic Stem Cell Transplantation in Southern Iran: History,Current Status and Future Direction
Stem cell Transplantation Hematopoietic Thalassemia major Hematologic malignancy Iran
2015/9/18
Transplantation of hematopoietic stem cells (HSCT) has become the standard treatment for many patients with congenital or acquired disorders of the hematopoietic system or with chemo-radio or immuno-s...
Secondary Malignancies After Hemopoietic Stem Cell Transplantation
Hemopoietic stem cell transplantation post-transplant malignancies
2009/6/24
Hemopoietic stem cell transplantation is being carried out for rapidly increasing numbers of patients. Survival probabilities have increased progressively, and most patients return to productive lives...
The EBMT Activity Survey on Hematopoietic Stem Cell Transplantation: A novel Instrument for Quality Control
Hematopoietic stem cell transplantation transplant activity economic factors public health
2009/6/24
The hematopoietic stem cell transplant activity survey of the European Group for Blood and Marrow Transplantation (EBMT) represents a novel modern tool in health care management. Introduced in 1990, ...
Autologous stem cell transplantation with moderate dose of Idarubicin and Busulphan as conditioning regimen in acute myelogenous leukemia
Acute myeloid leukemia Stem cell transplantation Idarubicin Busulphan
2015/9/11
Background: Over 50% of patients with AML still relapse after autologous stem cell transplantation. We investigated the efficacy and feasibility of a new conditioning regimen consisting of a moderate ...
Is There any Greater Possibility in Finding HLA-identical Unrelated Hematopoietic Stem Cell Donors among Thalassemia Families for Transplantation of Thalassemia Patients?
HLA Stem cell
2010/4/29
Thalassemia is probably the most common single gene disorder causing a major public health problem in the world. Currently, allogenic hematopoietic stem cell transplantation (HSCT) is the only curativ...
Non-Myeloablative Stem Cell Transplantation in Hematologic Malig¬nancies: An Experience from the Hematology-Oncology and BMT Re¬search Center
Hematopoietic stem cell transplantation Allogeneic Non-myeloablative Graft vs Host Dis¬ ease
2010/5/4
Background: Myeloablative-allogeneic stem cell transplantation is a common way of treating various malignant and nonma-lignant diseases; but, it is associated with hazardous immediate and late complic...